期刊文献+

Epidemiology,surveillance and control of methicillin-resistant Staphylococcus aureus:an Overview

Epidemiology,surveillance and control of methicillin-resistant Staphylococcus aureus:an Overview
收藏 分享 导出
摘要 【正】Staphylococcus aureus(S.aureus) is one of the most common human pathogens,causing a wide range of afflictions from minor infections of the skin to serious wound infections,bacteraemia,pneumonia and endocarditis. Methicillin,the first semisynthetic derivative of penicillin,was a new hope to treat penicillin resistant 5.aureus in the early 1960s.Nevertheless,only one year after its introduction,the first methicillin-resistant 5.aureus (MRSA) strains were detected.There is no golden rule in the control of MRSA.Nevertheless,using surveillance cultures of patients and healthcare personnel,strictly enforced contact precautions,and judicious use of broad-spectrum antibiotics have helped several countries,including Finland,Denmark,and the Netherlands to keep MRSA at a very low level.Conversely,countries including China,Japan,US,Italy,Greece,UK, where stringent counter-measure were not able to be installed,MRSA have become hyper-endemic.Control of MRSA in those countries were obliged to concentrate available resources to prevent MRSA infections only at patients at high risk of serious morbidity and mortality. Staphylococcus aureus(S.aureus) is one of the most common human pathogens,causing a wide range of afflictions from minor infections of the skin to serious wound infections,bacteraemia,pneumonia and endocarditis. Methicillin,the first semisynthetic derivative of penicillin,was a new hope to treat penicillin resistant 5.aureus in the early 1960s.Nevertheless,only one year after its introduction,the first methicillin-resistant 5.aureus (MRSA) strains were detected.There is no golden rule in the control of MRSA.Nevertheless,using surveillance cultures of patients and healthcare personnel,strictly enforced contact precautions,and judicious use of broad-spectrum antibiotics have helped several countries,including Finland,Denmark,and the Netherlands to keep MRSA at a very low level.Conversely,countries including China,Japan,US,Italy,Greece,UK, where stringent counter-measure were not able to be installed,MRSA have become hyper-endemic.Control of MRSA in those countries were obliged to concentrate available resources to prevent MRSA infections only at patients at high risk of serious morbidity and mortality.
作者 Li F DeWolfe Miller F Li F1,DeWolfe Miller F2 1 School of Social Work,University of Hawaii,Honolulu,HI 96822,USA 2 John A.Burns School of Medicine,University of Hawaii,Honolulu,HI96822,USA
出处 《亚太热带医药杂志:英文版》 SCIE 2008年第1期50-55,共6页 Asian Pacific Journal of Tropical Medicine
关键词 STAPHYLOCOCCUS AUREUS METHICILLIN SURVEILLANCE Staphylococcus aureus methicillin surveillance
  • 相关文献

参考文献45

  • 1李家泰,李耘,王进,中国细菌耐药监测研究组.中国医院和社区获得性感染革兰阳性球菌耐药性监测研究[J].中华医学杂志,2003,83(5):365-374. 被引量:195
  • 2Lowy FD.Antimicrobial resistance: the example of Staphylococcus aureus. The Journal of Clinical Investigation . 2003 被引量:2
  • 3Chambers HF.The changing epidemiology of Staphylococcus aureus?. Emerging Infections . 2001 被引量:1
  • 4Centers for Disease Control and Prevention CDC.Vancomycin-resistantStaphylococcus aureus-Pennsylvania,2002. MMWR Morb Mortal WklyRep . 2002 被引量:1
  • 5Klevens RM,Morrison MA,Nadle J,et al.Invasivemethicillin-resistant Staphylococcus aureus infections inthe United States. The Journal of The American Medical Association . 2007 被引量:1
  • 6JM Boyce,B Cookson,K Christiansen,S Hori,J Vuopio-Varkila,S Kocagoz,AY Oztop,CM Vandenbroucke-Grauls,S Harbarth,D Pittet.Methicillin-resistant Staphylococcus aureus. The Lancet Infectious Diseases . 2005 被引量:2
  • 7Wilton,P,Smith,R,Coast,J,Millar,M.Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness. J Health Serv Res Policy . 2002 被引量:1
  • 8S. Park,S.B. Soumerai,A.S. Adams,J.A. Finkelstein,S. Jang,D. Ross-Degnan.Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians. Health Policy and Education . 2005 被引量:1
  • 9EA Belongia,MJ Knobloch,BA Kieke,JP Davis,C Janette,RE Besser.Impact of statewide program to promote appropriate antimicrobial drug use. Emerging Infectious Diseases . 2005 被引量:1
  • 10Boyce. Infection Control and Hospital Epidemiology . 2002 被引量:1

二级参考文献12

  • 1National Committee for Clinical Laboratory Standard 2001. Performance standards for antimicrobial susceptibility testing. NCCLS, Wayne, Pa M2-A7 and M7-AS.2001. 被引量:1
  • 2Jeljaszewicz J, Mlynarczyk G, Mlynarczyk A. Antibiotic resistance in Gram-positive cocci. Int J Antimicrob Chemother,2000,16:473-478. 被引量:1
  • 3Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet, 1997,350:1670-1673. 被引量:1
  • 4Centers for Disease Control. Staphylococcus aureus with reduced susceptibility to vancomycin-United States 1997. CDC MMWR Morb Mortal Wkly Rep 1997,46:765-766. 被引量:1
  • 5Centers for Disease Control. Staphylococcus aureus resistance to vancomycin-United States, 2002. CDC MMWR Morb Mortal Wkly Rep,2002,51:565-567. 被引量:1
  • 6Centers for Disease Control. Public health dispatch: vancomycin resistant Staphylococcus aureus-pennsylvania, 2002. CDC MMWR Morb Mortal Wkly Rep, 2002,51: 902. 被引量:1
  • 7Li JT, Zhang Y Chen YF, et al. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillinresistant pneumococci. Chin Med J, 2000,113: 628-631. 被引量:1
  • 8Felmingham D, Gruneberg RN and the Alexander Project group. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chenother,2000,45:191-203. 被引量:1
  • 9Felmingham D, Washington J. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens finding for the Alexander Project 1992-1996. J Chemother, 1999,11 ( Suppl 1 ): 5-21. 被引量:1
  • 10Jones RN, Pfaller MA. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.Clin Infect Dis, 2000,31(Suppl 2) :S16-S23. 被引量:1

共引文献198

投稿分析
职称考试

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈